Skip to content


Ranexa, Latixa (ranolazine) is a small molecule pharmaceutical. Ranolazine was first approved as Ranexa on 2006-01-27. It is used to treat angina pectoris in the USA. It has been approved in Europe to treat angina pectoris.
Trade Name Latixa, Ranexa
Common Name Ranolazine
Indication angina pectoris
Drug Class Antiarrhythmic/antianginal/antihypertensive agents, phthalazine like structure
Get full access now